Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon P Hart

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Thorax|January 10, 2020
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)Irene J Higginson, Andrew Wilcock, Miriam J Johnson, et al.
Cellular and Molecular Life Sciences : CMLS|October 19, 2010
Heat-shock protein 60 translocates to the surface of apoptotic cells and differentiated megakaryocytes and stimulates phagocytosisYaw Chong Goh, Celestial T Yap, Bao Hua Huang, et al.
ERJ Open Research|December 2, 2020
Azithromycin for sarcoidosis cough: an open-label exploratory clinical trialSimon D Fraser, Susannah Thackray-Nocera, Marica Shepherd, et al.
Journal of Palliative Medicine|February 4, 2016
The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung DiseaseJason W Boland, Carla Reigada, Janelle Yorke, et al.
ERJ Open Research|October 26, 2019
A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocolCaroline Wright, Simon P Hart, Victoria Allgar, et al.
ERJ Open Research|June 24, 2026
Measuring the effect of azithromycin in chronic respiratory disease using continuous cough monitoring: an open-label exploratory trialDominic L Sykes, Kayleigh Brindle, Syed Kazmi, et al.
Trends in Ecology & Evolution|December 23, 2020
On the Origin of Coexisting SpeciesRachel M Germain, Simon P Hart, Martin M Turcotte, et al.
The European Respiratory Journal|March 12, 2026
Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): A randomized, double-blinded, multicenter, Phase 2 studyBernt Van Den Blink, Surinder S Birring, Nesrin Mogulkoc, et al.
The Lancet. Healthy Longevity|April 27, 2026
The crucial role of normative ageing in respiratory pathogenesis, Caroline M Weight, Amanda L Tatler, et al.
Health Technology Assessment (Winchester, England)|May 9, 2026
Comparing the effectiveness, cost-effectiveness and implementation of low-dose oral modified release morphine in people with chronic breathlessness: a synopsis of a RCT and process evaluationMiriam J Johnson, Bronwen Williams, Catriona Keerie, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Thorax|January 10, 2020
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)Irene J Higginson, Andrew Wilcock, Miriam J Johnson, et al.
Cellular and Molecular Life Sciences : CMLS|October 19, 2010
Heat-shock protein 60 translocates to the surface of apoptotic cells and differentiated megakaryocytes and stimulates phagocytosisYaw Chong Goh, Celestial T Yap, Bao Hua Huang, et al.
ERJ Open Research|December 2, 2020
Azithromycin for sarcoidosis cough: an open-label exploratory clinical trialSimon D Fraser, Susannah Thackray-Nocera, Marica Shepherd, et al.
Journal of Palliative Medicine|February 4, 2016
The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung DiseaseJason W Boland, Carla Reigada, Janelle Yorke, et al.
ERJ Open Research|October 26, 2019
A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocolCaroline Wright, Simon P Hart, Victoria Allgar, et al.
ERJ Open Research|June 24, 2026
Measuring the effect of azithromycin in chronic respiratory disease using continuous cough monitoring: an open-label exploratory trialDominic L Sykes, Kayleigh Brindle, Syed Kazmi, et al.
Trends in Ecology & Evolution|December 23, 2020
On the Origin of Coexisting SpeciesRachel M Germain, Simon P Hart, Martin M Turcotte, et al.
The European Respiratory Journal|March 12, 2026
Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): A randomized, double-blinded, multicenter, Phase 2 studyBernt Van Den Blink, Surinder S Birring, Nesrin Mogulkoc, et al.
The Lancet. Healthy Longevity|April 27, 2026
The crucial role of normative ageing in respiratory pathogenesis, Caroline M Weight, Amanda L Tatler, et al.
Health Technology Assessment (Winchester, England)|May 9, 2026
Comparing the effectiveness, cost-effectiveness and implementation of low-dose oral modified release morphine in people with chronic breathlessness: a synopsis of a RCT and process evaluationMiriam J Johnson, Bronwen Williams, Catriona Keerie, et al.
Pageof 11